Molecular and Circulating Biomarkers in Patients with Glioblastoma

Glioblastoma is the most aggressive malignant tumor of the central nervous system with a low survival rate. The difficulty of obtaining this tumor material represents a major limitation, making the real-time monitoring of tumor progression difficult, especially in the events of recurrence or resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Senhaji, Nadia, Squalli Houssaini, Asmae, Lamrabet, Salma, Louati, Sara, Bennis, Sanae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267689/
https://www.ncbi.nlm.nih.gov/pubmed/35806478
http://dx.doi.org/10.3390/ijms23137474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267689/
https://www.ncbi.nlm.nih.gov/pubmed/35806478
http://dx.doi.org/10.3390/ijms23137474

Ejemplares similares